✦ LIBER ✦

First-Line Bevacizumab-Based Therapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer

✍ Scribed by Alessandra Bearz, Rodolfo Passalacqua, Oscar Alabiso, Saverio Cinieri, Cesare Gridelli, Claudia Cravesana, Lucio Crinò

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of first-line bevaci

✍ Lucio Crinò; Eric Dansin; Pilar Garrido; Frank Griesinger; Janessa Laskin; Nick 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 204 KB

Bevacizumab and erlotinib (BE) first-lin

✍ Zappa, Francesco; Droege, Cornelia; Betticher, Daniel; von Moos, Roger; Bubendor 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Second-line therapy for advanced non-sma

✍ Christine L. Hann; Julie R. Brahmer 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 90 KB

22IN SECOND-LINE THERAPY FOR ADVANCED NO

✍ Cullen, M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Randomized phase II study of first-line

✍ Niho, Seiji; Kunitoh, Hideo; Nokihara, Hiroshi; Horai, Takeshi; Ichinose, Yukito 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Effectiveness of bevacizumab- and pemetr

✍ Nuijten, Mark; Heigener, David F.; Bischoff, Helge G.; Chouaid, Christos; Vergne 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 145 KB